Why the study?
Does complete revascularization reduce major adverse cardiac events compared to culprit-only intervention in patients with STEMI and multivessel disease?
Does complete revascularization reduce major adverse cardiac events compared to culprit-only intervention in patients with STEMI and multivessel disease?
Answers are grounded in this paper and cite their sources.
In STEMI patients with multivessel disease, complete revascularization reduces MACE, cardiac death, and the need for repeat revascularization without improving all-cause mortality or nonfatal MI.
Our results suggest that in patients with STEMI and multivessel disease, complete revascularization is safe, and is associated with reduced risks of major adverse cardiac events and cardiac death along with a reduced need for repeat revascularization. However, it showed no beneficial effect on all-cause mortality and nonfatal myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Vaidya et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: